Physician profile
Heather Auld
NPI 1396727178
$435.11
in general payments reported to CMS, 2019-2025
10 companies · $83.35 in 2025
The $83.35 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.68 · 2020: $34.87 · 2021: $74.90 · 2022: $127 · 2023: $62.86 · 2024: $30.64 · 2025: $83.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $158 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $157.58 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $89.59 | 2021-2022 | |
| Therapeuticsmd, INC. | $88.56 | 2019-2022 | |
| Pfizer INC. | $56.47 | 2022-2023 | |
| Exeltis, USA INC. | $54.86 | 2022-2025 | Slynd |
| Mayne Pharma Commercial LLC | $39.03 | 2022-2023 | |
| Astellas Pharma US INC | $38.07 | 2025 | Veozah |
| Sumitomo Pharma America, INC. | $23.96 | 2025 | Myfembree |
| Romark Laboratories, Lc | $16.42 | 2020 | |
| Avion Pharmaceuticals | $14.76 | 2022 | |
| Acella Pharmaceuticals, LLC | $13.39 | 2024 | NP Thyroid 60 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Auld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.